BIOFACTORS, an esteemed journal published by Wiley, serves as a pivotal resource in the fields of Biochemistry, Clinical Biochemistry, and Molecular Medicine. With ISSN 0951-6433 and E-ISSN 1872-8081, the journal has established its reputation since its inception in 1988, showcasing a rich history of scientific inquiry and innovation. Recognized for its high academic standards, it currently holds a Q1 ranking in key categories, including Biochemistry and Medicine (miscellaneous), and ranks in the top 10% for Clinical Biochemistry according to Scopus metrics, reflecting its impact and influence in the scientific community. Although it does not offer Open Access, BIOFACTORS provides researchers the opportunity to publish and disseminate high-quality studies that advance our understanding of biological factors and their clinical implications. The journal actively encourages contributions that bridge the gap between laboratory findings and clinical applications, making it a vital platform for both seasoned researchers and emerging scholars in the life sciences.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, published by Academic Press Inc Elsevier Science, stands as a leading periodical in the fields of biochemistry, biophysics, cell biology, and molecular biology. With an ISSN of 0006-291X and an E-ISSN of 1090-2104, this esteemed journal has been a pivotal platform for the dissemination of groundbreaking research since its inception in 1959, continuing to publish influential findings through at least 2024. It holds a commendable Q2 ranking in Biochemistry and Q1 status in Biophysics as of 2023, reflecting its high impact and relevance in the field, supported by its strong Scopus rankings—ranking #43 in Biophysics and maintaining a presence in the top quartiles of several related categories. Although it is not an open-access journal, it provides critical insights and essential data that cater to researchers, professionals, and students keen on advancing their understanding of complex biochemical and biophysical processes. Its significant contributions to the scientific community underscore the importance of this journal as a reference point for innovative research and collaborative discourse.

Frontiers in Bioscience-Landmark is a prestigious journal published by IMR PRESS that focuses on a diverse array of topics within the fields of biochemistry, genetics, molecular biology, immunology, and microbiology. With the ISSN 2768-6701 and E-ISSN 2768-6698, this journal has carved a significant niche since its inception in 1996, making its mark in contributions to the scientific community all the way through to 2024. Having achieved a respectable Q2 cohort rank in multiple categories, including biochemistry and immunology, it stands out for its impactful research, evidenced by its current Scopus rankings which highlight it as a vital resource for ongoing studies and advancements in the biosciences. Despite not being open access, the journal ensures that readers have access to high-quality research articles that are peer-reviewed and designed to foster academic discourse. The importance of Frontiers in Bioscience-Landmark lies in its commitment to disseminating innovative findings that can significantly enhance our understanding of biological sciences, making it an essential read for researchers, professionals, and students alike.

Reports of Biochemistry and Molecular Biology, published by VARASTEGAN INST MEDICAL SCIENCES, is a distinguished open access journal dedicated to advancing the fields of biochemistry and molecular biology. Since its inception in 2012, the journal has fostered a platform for researchers and professionals to disseminate their findings, contributing to a richer understanding of biochemical processes and molecular mechanisms. With a focus on innovative research and technology, the journal has established itself as a significant resource within its field, being classified in the Q3 category for Biochemistry and Molecular Biology by 2023. Notably, it has achieved respectable Scopus rankings, including a rank of #40/72 in Biochemistry (medical) as well as a common ground across multiple related categories. The journal’s commitment to open access ensures that its valuable content is freely available to the global scientific community, facilitating knowledge sharing among students, researchers, and professionals alike. Located in Mashhad, Iran, Reports of Biochemistry and Molecular Biology serves as a bridge between cutting-edge research and practical applications in the biochemistry and molecular biology domains.

CURRENT CANCER DRUG TARGETS is a prominent academic journal published by Bentham Science Publishers Ltd, focusing on the critical intersection of cancer research and innovative drug development. Since its inception in 2001, this journal has offered a platform for the dissemination of cutting-edge research aimed at advancing targeted cancer therapies, contributing significantly to the fields of Cancer Research, Drug Discovery, Oncology, and Pharmacology. With a respectable impact factor and consistent ranking in its respective categories, including Q2 in Drug Discovery and Pharmacology, it positions itself as an invaluable resource for researchers, clinicians, and students alike. CURRENT CANCER DRUG TARGETS is dedicated to enhancing our understanding of novel therapeutic targets and methods, thereby fostering a collaborative environment for knowledge exchange in the ever-evolving landscape of cancer treatment.

JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, published by TAYLOR & FRANCIS LTD, is a premier academic journal dedicated to advancing our understanding of receptor biology and signal transduction mechanisms. With an ISSN of 1079-9893 and an E-ISSN of 1532-4281, this journal has maintained a reputable standing since its inception in 1980, continually addressing pivotal topics in biochemistry, cell biology, and molecular biology. As evidenced by its 2023 Scopus rankings, which place it in the 64th percentile for Biochemistry and Genetics and Molecular Biology, JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION remains a vital source for cutting-edge research, providing insights that are essential for both academic and practical applications. Although the journal currently offers limited open access options, it stands out in the Q2 and Q3 quartiles of its respective categories, making it an invaluable resource for researchers, professionals, and students aiming to stay abreast of the latest findings and methodologies in receptor and signaling research. The journal's commitment to disseminating high-quality research underscores its significance within the scientific community, fostering innovation and collaboration across disciplines.

CELL BIOCHEMISTRY AND FUNCTION is a prominent journal dedicated to disseminating high-quality research in the fields of biochemistry, cell biology, and clinical biochemistry. Published by Wiley, this journal has maintained an esteemed reputation since its inception in 1983, bridging decades of scientific advancements and contributions until 2024. With ISSN 0263-6484 and E-ISSN 1099-0844, it serves as a vital resource for researchers, professionals, and students. The journal is classified in quartiles Q2 and Q3 across various categories in the 2023 rankings, showcasing its impact and significance within the academic community. Highlighting essential studies in medicinal biochemistry and cellular functionalities, CELL BIOCHEMISTRY AND FUNCTION not only presents cutting-edge research but also encourages interdisciplinary collaboration, thereby advancing the understanding of biochemical processes that underlie living systems. With no open access currently available, readers are encouraged to access articles through institutional subscriptions or individual purchases, ensuring exclusive engagement with the latest scientific findings in this dynamic field.

BioImpacts, an esteemed journal published by Tabriz University of Medical Sciences & Health Services, is a prominent platform dedicated to advancing the fields of Biochemistry, Genetics, Molecular Biology, Medicine, and Pharmaceutical Science. Established in 2011, this Open Access journal ensures that vital research findings are freely accessible to the global academic community. With an impressive presence in the Scopus database, BioImpacts currently holds a Q2 quartile ranking in its respective categories, reflecting its contribution to scientific discourse and its importance as a critical resource for researchers and practitioners alike. The journal's dynamic scope encompasses a wide range of topics, highlighting innovative research that addresses contemporary challenges in health and disease. Operating out of Tabriz, Iran, BioImpacts is committed to fostering interdisciplinary collaboration and knowledge dissemination through their dedicated publication efforts, which span from 2011 to 2024. Researchers, professionals, and students are encouraged to explore the rich content and cutting-edge studies presented in this journal, making it an indispensable resource in the scientific community.

ENDOCRINE JOURNAL, published by the Japan Endocrine Society, is a pivotal resource for researchers and professionals in the field of endocrinology, diabetes, and metabolism. With a long history dating back to 1954, this journal encompasses a comprehensive range of topics including hormonal regulation, pathophysiology of endocrine diseases, and innovative therapeutic approaches. Despite its classification as open access, the journal remains a beacon of knowledge, with impressive rankings—Q2 in Endocrinology, Diabetes and Metabolism and Q3 in Endocrinology for 2023—ensuring it is a respected source in the academic community. It serves as a critical platform for the dissemination of cutting-edge research, encouraging collaboration and facilitating advancements in understanding complex endocrine disorders. By subscribing to this journal, researchers and students gain access to seminal studies, clinical insights, and a wealth of information that drives this vital field forward.

Cellular Physiology and Biochemistry is a premier Open Access journal published by the prestigious Cell Physiol Biochem Press GmbH & Co, dedicated to advancing research in the fields of physiology, biochemistry, and molecular biology. Since its inception in 1987 and transitioning to an Open Access model in 2013, the journal has established itself as a vital resource for the dissemination of high-quality research and reviews, showcasing innovative methodologies and groundbreaking findings in cellular processes. With an impressive ranking in the 2023 Scopus category as Q2 in Physiology and a robust percentile of 61, Cellular Physiology and Biochemistry is committed to fostering academic dialogue among researchers, professionals, and students alike. This journal not only provides unrestricted access to its articles, but also promotes the global sharing of knowledge, which is essential for the advancement of our understanding in these vital scientific areas. The journal's editorial team is dedicated to ensuring the highest standards of academic rigor and relevance, making it an indispensable addition to the libraries of those engaged in the life sciences.